Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONTRAST MEDIA/CONTRAST AGENTS INDUSTRY
2.1 Summary about Contrast Media/Contrast Agents Industry
2.2 Contrast Media/Contrast Agents Market Trends
2.2.1 Contrast Media/Contrast Agents Production & Consumption Trends
2.2.2 Contrast Media/Contrast Agents Demand Structure Trends
2.3 Contrast Media/Contrast Agents Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Iodinated
4.2.2 Gadolinium-Based
4.2.3 Barium-Based
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cardiology
4.3.2 Oncology
4.3.3 Neurology
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Iodinated
5.2.2 Gadolinium-Based
5.2.3 Barium-Based
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cardiology
5.3.2 Oncology
5.3.3 Neurology
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Iodinated
6.2.2 Gadolinium-Based
6.2.3 Barium-Based
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cardiology
6.3.2 Oncology
6.3.3 Neurology
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Iodinated
7.2.2 Gadolinium-Based
7.2.3 Barium-Based
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cardiology
7.3.2 Oncology
7.3.3 Neurology
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Iodinated
8.2.2 Gadolinium-Based
8.2.3 Barium-Based
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cardiology
8.3.2 Oncology
8.3.3 Neurology
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Iodinated
9.2.2 Gadolinium-Based
9.2.3 Barium-Based
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cardiology
9.3.2 Oncology
9.3.3 Neurology
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Guerbet Group
10.1.2 Bayer Healthcare
10.1.3 Bracco Diagnostic
10.1.4 Covidien
10.1.5 GE Healthcare
10.1.6 Eli Lilly
10.1.7 Alseres Pharmaceuticals
10.1.8 Aposense
10.1.9 Yangtze River Pharmaceutical
10.1.10 Jiangsu Hengrui Medicine
10.1.11 Shanghai Xudong Haipu Pharmaceutical
10.2 Contrast Media/Contrast Agents Sales Date of Major Players (2017-2020e)
10.2.1 Guerbet Group
10.2.2 Bayer Healthcare
10.2.3 Bracco Diagnostic
10.2.4 Covidien
10.2.5 GE Healthcare
10.2.6 Eli Lilly
10.2.7 Alseres Pharmaceuticals
10.2.8 Aposense
10.2.9 Yangtze River Pharmaceutical
10.2.10 Jiangsu Hengrui Medicine
10.2.11 Shanghai Xudong Haipu Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Contrast Media/Contrast Agents Product Type Overview
Table Contrast Media/Contrast Agents Product Type Market Share List
Table Contrast Media/Contrast Agents Product Type of Major Players
Table Brief Introduction of Guerbet Group
Table Brief Introduction of Bayer Healthcare
Table Brief Introduction of Bracco Diagnostic
Table Brief Introduction of Covidien
Table Brief Introduction of GE Healthcare
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Alseres Pharmaceuticals
Table Brief Introduction of Aposense
Table Brief Introduction of Yangtze River Pharmaceutical
Table Brief Introduction of Jiangsu Hengrui Medicine
Table Brief Introduction of Shanghai Xudong Haipu Pharmaceutical
Table Products & Services of Guerbet Group
Table Products & Services of Bayer Healthcare
Table Products & Services of Bracco Diagnostic
Table Products & Services of Covidien
Table Products & Services of GE Healthcare
Table Products & Services of Eli Lilly
Table Products & Services of Alseres Pharmaceuticals
Table Products & Services of Aposense
Table Products & Services of Yangtze River Pharmaceutical
Table Products & Services of Jiangsu Hengrui Medicine
Table Products & Services of Shanghai Xudong Haipu Pharmaceutical
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Contrast Media/Contrast Agents Market Forecast (Million USD) by Region 2021f-2026f
Table Global Contrast Media/Contrast Agents Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Contrast Media/Contrast Agents Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Contrast Media/Contrast Agents Market Forecast (Million USD) Share by Demand 2021f-2026f